First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS
Clinical trial NCT03231722 · COMPLETED
Trial details
- NCT number
- NCT03231722
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-13
- Primary completion
- 2022-06-15
- Enrollment
- 435
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.